TY - JOUR T1 - Pulmonary hypertension and chronic lung disease: where are we headed? JF - European Respiratory Review JO - EUROPEAN RESPIRATORY REVIEW DO - 10.1183/16000617.0065-2019 VL - 28 IS - 153 SP - 190065 AU - Davide Elia AU - Antonella Caminati AU - Maurizio Zompatori AU - Roberto Cassandro AU - Chiara Lonati AU - Francesca Luisi AU - Giuseppe Pelosi AU - Steeve Provencher AU - Sergio Harari Y1 - 2019/09/30 UR - http://err.ersjournals.com/content/28/153/190065.abstract N2 - Pulmonary hypertension related to chronic lung disease, mainly represented by COPD and idiopathic pulmonary fibrosis, is associated with a worse outcome when compared with patients only affected by parenchymal lung disease. At present, no therapies are available to reverse or slow down the pathological process of this condition and most of the clinical trials conducted to date have had no clinically significant impact. Nevertheless, the importance of chronic lung diseases is always more widely recognised and, along with its increasing incidence, associated pulmonary hypertension is also expected to be growing in frequency and as a health burden worldwide. Therefore, it is desirable to develop useful and reliable tools to obtain an early diagnosis and to monitor and follow-up this condition, while new insights in the therapeutic approach are explored.New prospective in the management of pulmonary hypertension related to chronic lung diseases http://bit.ly/2lW4CfE ER -